Business Wire | Sep 28, 2020 08:30AM EDT

Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

Sep. 28, 2020

BRISBANE, Calif.--(BUSINESS WIRE)--Sep. 28, 2020--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present at the following investor conferences:

* Jefferies Virtual Gene Therapy / Editing Summit Thursday, October 1st at 12:00 pm Eastern Time

* Chardan Genetic Medicines Conference Monday, October 5th at 8:00 a.m. Eastern Time

Presentations will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will also be available on the Sangamo website after the event.

About Sangamo Therapeutics

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients' lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and genome regulation. For more information about Sangamo, visit www.sangamo.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200928005203/en/

CONTACT: Investor Relations - Global McDavid Stilwell 510-970-6000, x219 mstilwell@sangamo.com